Sg Americas Securities, LLC Relay Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$6.01 - $11.48 $321,889 - $614,857	53,559 Added 139.43%	91,973 $1.01 Million
Q3 2023 Oct 13, 2023	BUY	$8.24 - $12.97 $316,531 - $498,229	38,414 New	38,414 $323,000
Q4 2022 Feb 02, 2023	BUY	$14.16 - $24.02 $75,033 - $127,281	5,299 Added 43.61%	17,450 $261,000
Q3 2022 Oct 31, 2022	SELL	$18.07 - $31.37 $1.3 Million - $2.25 Million	-71,713 Reduced 85.51%	12,151 $272,000
Q2 2022 Jul 29, 2022	BUY	$13.31 - $34.88 $514,311 - $1.35 Million	38,641 Added 85.45%	83,864 $1.41 Million

Q1 2022 Apr 29, 2022	SELL	$20.26 - $32.36 $51,703 - $82,582	-2,552 Reduced 5.34%	45,223 $1.35 Million
Q4 2021 Feb 07, 2022	SELL	$26.0 - $37.03 $1.12 Million - $1.59 Million	-42,965 Reduced 47.35%	47,775 $1.47 Million
Q3 2021 Nov 01, 2021	BUY	$29.75 - $37.99 $1.85 Million - $2.37 Million	62,351 Added 219.63%	90,740 $2.86 Million
Q2 2021 Aug 12, 2021	SELL	$27.5 - $38.19 $85,827 - $119,190	-3,121 Reduced 9.9%	28,389 $1.04 Million
Q1 2021 May 13, 2021	BUY	$32.52 - $61.53 $260,355 - $492,609	8,006 Added 34.06%	31,510 $1.09 Million
Q4 2020 Feb 04, 2021	BUY	$35.51 - $54.03 $834,627 - $1.27 Million	23,504 New	23,504 $977,000

187

127M

4.2K

1.7K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $834M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg Americas Securities, LLC with notifications on news.